NCT03403179

Brief Summary

Bipolar Disorder is a major mood disorder with periodic mood episodes that may be very distressing, both to the individual and to others. When ill, the person is at particular risk for disruptions to social and occupational functioning, physical health, and even premature death. When not in an episode, individuals with BD may still be feeling well but have ongoing neurobiological processes, as well as the psychological sequelae from illness episodes, that can lead to subtle neurocognitive impairment that impedes overall functioning. This study is a test of an existing, published intervention that ameliorates deficits in functioning in euthymic bipolar individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 17, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 11, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 18, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2018

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2018

Completed
Last Updated

February 28, 2019

Status Verified

February 1, 2019

Enrollment Period

1.1 years

First QC Date

January 11, 2018

Last Update Submit

February 27, 2019

Conditions

Keywords

CognitionCognitive RemediationMood DisorderFunctional ImpairmentPsychosocial intervention

Outcome Measures

Primary Outcomes (3)

  • Feasibility

    Feasibility will be determined by a composite of ability to recruit and deliver the treatment intervention to both cohorts of participants, with adequate delivery of the intervention as measured by completion of the manual's objectives.

    30 weeks

  • Acceptability (Subject Satisfaction)

    Acceptability of the intervention will be measured by use of the Satisfaction with Therapy and Therapist Scale.

    30 weeks

  • Acceptability (Subject completion)

    Measured by percentage of subjects who complete the intervention.

    30 weeks

Secondary Outcomes (1)

  • Functional Impact

    30 weeks

Study Arms (1)

Receiving Psychosocial Intervention

EXPERIMENTAL

Functional Remediation: The functional remediation program consists of 21 weekly sessions, each lasting 90 min. This intervention addresses neurocognitive issues such as attention, memory and executive functions, but it focuses even more on enhancing functioning in daily routine. The content of the intervention is based on ecological tasks to be performed in two settings, in the clinic as well as at home. Participants will be trained with exercises for memory, attention, problem solving and reasoning, multitasking and organization in order to improve their functional outcome. Most of the techniques are based on paper-and-pencil tasks and group activities.

Other: Functional Remediation

Interventions

Functional Remediation: The functional remediation program consists of 21 weekly sessions, each lasting 90 min. This intervention addresses neurocognitive issues such as attention, memory and executive functions, but it focuses even more on enhancing functioning in daily routine. The content of the intervention is based on ecological tasks to be performed in two settings, in the clinic as well as at home. Participants will be trained with exercises for memory, attention, problem solving and reasoning, multitasking and organization in order to improve their functional outcome. Most of the techniques are based on paper-and-pencil tasks and group activities.

Receiving Psychosocial Intervention

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • diagnosis of bipolar I or II disorder (BD), as determined by a structured diagnostic interview
  • at least three months of clinical remission (euthymia or minimal symptoms), based on the phone screen assessing mood episodes in the prior three months
  • score greater than 11 on a measure of everyday functioning (FAST; described in measures section) indicating at least mild impairment
  • use of a standard bipolar mood-stabilizing medication at the same, adequate dose (according to CANMAT treatment guidelines) for at least 3 months prior to screening, with ability to continue that dose during the study.

You may not qualify if:

  • history of neurological illness or injury (e.g., stroke, brain tumor)
  • documented intellectual disability
  • inability to provide written informed consent
  • substance dependence within last 3 months or substance abuse in last 30 days
  • inability to complete the six-month intervention
  • received ECT in the past 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan Depression Center

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Bipolar DisorderMood Disorders

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMental Disorders

Study Officials

  • Sagar Parikh, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: This study is a single center, open-label, outpatient clinical trial with no randomization or blinding. The Barcelona Functional Remediation for Bipolar Disorder (FR) Program will be tested over a 21-week period using 30 participants split into two equal cohorts. The study will evaluate the feasibility and preliminary efficacy of the intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Psychiatry

Study Record Dates

First Submitted

January 11, 2018

First Posted

January 18, 2018

Study Start

November 17, 2017

Primary Completion

December 10, 2018

Study Completion

December 20, 2018

Last Updated

February 28, 2019

Record last verified: 2019-02

Locations